Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Nova Dubnica

202 clinical trials in Nova Dubnica, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Nova Dubnica at a glance
202
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

202 trials in Nova Dubnica

Open in trial search

A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Orelabrutinib
  • Sponsor:Zenas Biopharma (USA) LLC

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Efficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:LY4268989 adipic acid
  • Sponsor:Eli Lilly & Co.

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Agitation+1

Recruiting

A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Deramciclane
  • Sponsor:Exciva GmbH

A study comparing furazidin and clindamycin for women with bacterial vaginosis

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Furazidine
  • Sponsor:Adamed Pharma S.A.

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Colorectal cancer+1

Recruiting

Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:NGM120
  • Sponsor:Ngm Biopharmaceuticals Inc.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Nova Dubnica

What the registry says about research in the country

01 Neurodegenerative Disorders

Clinical research focusing on Alzheimer's Disease treatments, including studies evaluating new therapies for early-stage patients with inflammatory biomarkers and investigating treatments for agitation in dementia patients.

  • Early Alzheimer's Disease Management
  • Dementia-Related Agitation
  • Inflammatory Biomarkers

These trials aim to improve cognitive performance and quality of life for patients with neurodegenerative conditions.

02 Epilepsy Studies

Comprehensive research into various forms of epilepsy, with particular focus on developing treatments for primary generalized tonic-clonic seizures and absence epilepsy in younger patients.

  • Childhood Absence Epilepsy
  • Juvenile Absence Epilepsy
  • Tonic-Clonic Seizure Management

Clinical investigations are evaluating both short-term efficacy and long-term safety of anticonvulsant therapies.

03 Neurological Pain Management

Innovative research exploring preventative treatments for migraine patients who have not responded to conventional therapies, testing new approaches to chronic pain management.

  • Treatment-Resistant Migraine
  • Preventative Therapies
  • Novel Pain Management Approaches

These studies focus on developing alternative solutions for patients with difficult-to-treat neurological pain conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.